RxDoctor Payments Data

Stephen Ferzoco, MD

Surgery · Dedham, MANPI 1508823808

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $73,800 of the $75,961 with a category attached, or 97.2%. Every reported general payment came from a single manufacturer, TELA Bio, Inc.. Reporting peaked in 2019 at $39,522 and has fallen 99.2% since, to $312 in 2024. Among surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$75,961in general payments, 2019–2025

Across 37 payments — averaging $2053.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$76K

What the payments were for

  • Consulting fees$73,80097%
  • Travel & lodging$1,1532%
  • Food & beverage$1,0071%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
TELA Bio, Inc.37$75,961

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$75,961 in reported general payments places this provider in the 95th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$116,334
Medicare patients
302
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam13$54
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$52

Paid to pharmacies, not to this prescriber.

Other surgery in Dedham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →